US pharmaceutical giant Johnson & Johnson's COVID-19 vaccine shows strong immune response

US pharmaceutical giant Johnson & Johnson's potential COVID-19 vaccine is reported to have shown a strong immune response to vel coronavirus with a single dose in early trial sts. Johnson & Johnson’s potential COVID-19 vaccine is fourth vaccine candidate to enter final phase of clinical trials.

Re: IOC President Bach Offers Pep Session For Tokyo Games And Talks Up Vaccine

Fourth US potential COVID-19 vaccine in final phase of trials

" safety profile and immugenicity after only a single dose are supportive for furr clinical development of [vaccine] 26.COV2.S at a dose level of 5x1010 vp, as a potentially protective vaccine against COVID-19”, report published on medical website medRxiv said on Friday. It also ded that just one single dose of vaccine resulted in a strong response to COVID-19 virus in a majority of recipients.

As per John Hopkins coronavirus resource centre, United States has reported a total of at least 6.5 million positive virus cases with death toll reaching over 196,000. US currently has highest number of reported cases in world, making it epicentre of virus. COVID-19 virus has mand to infect more than 29 million people worldwide.

Re: Pope Francis: Poor Need Priority Access To Vaccine COVID-19 vaccine to Americans free of charge

Trump ministration on September 16 revealed its delivery plan for COVID-19 vaccine and said that vaccine would be provided to all US citizens free of charge. As per reports, Trump ministration plans on delivering a ‘safe and effective’ COVID-19 vaccine to multiple sites with cost for providers and out of pocket charge for recipient.

statement also revealed that re may be limited availability of vaccine in initial sts and in such an event, front line workers and essential workers would be given priority and that while Pentagon would be assisting in its distribution, vaccine would only be ministered by civilian health workers.

(With ANI inputs)

Re: China Aims To Make 1 Billion COVID Vaccine Doses In 2021

Re: New York To Conduct Separate Review Of Trump-approved COVID-19 Vaccine